Sector revisions Roivant Sciences Ltd.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-09 pm EDT			5-day change	1st Jan Change
11.22 ^USD	+3.31%		+2.56%	-5.16%

Jun. 25	Roivant Sciences Insider Sold Shares Worth $1,145,000, According to a Recent SEC Filing	MT
Jun. 10	Roivant Sciences Ltd. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 04:00 PM

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	ROIVANT SCIENCES LTD.							8
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							23
	ABBVIE INC.							27
	NOVO NORDISK A/S							22
	ROCHE HOLDING AG							20
	NOVARTIS AG							19
	ASTRAZENECA PLC							20
	MERCK & CO., INC.							24
	AMGEN INC.							28
	PFIZER, INC.							23
	GILEAD SCIENCES, INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	BRISTOL-MYERS SQUIBB COMPANY							22
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI MEDICINE CO., LTD.							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	Average							21
	Weighted average by Cap.							23